Health

Results: 5797-5808 of 8162

PR Newswire associated0

Menarini Group Presents Updated Data from ELECTRA and ELEVATE Combination Studies of Elacestrant (ORSERDU®) in Patients with ER+, HER2- Metastatic Breast Cancer (mBC) at the ASCO 2024 Annual Meeting

Celltrion receives European Commission approval of Omlyclo® (CT-P39), the first and only omalizumab biosimilar approved in Europe

ONCOCLÍNICAS APPROVES R$ 1.5 BILLION CAPITAL INCREASE

Merus Announces Publication of Abstracts for Presentation at the 2024 ASCO® Annual Meeting

Merus Announces Publication of an Abstract on Petosemtamab with Pembrolizumab as 1L treatment of r/m HNSCC at the 2024 ASCO® Annual Meeting

Photocure ASA - Annual general meeting held

Over the past 25 years, Smile Train has seen the impact of supporting timely, affordable, high-quality cleft surgery for those who need it most. Since inception, the organisation has supported more than two million cleft surgeries, awarded more than £30 million in education and training grants to medical professionals, supported 600,000+ families with funding for costs related to accessing cleft care, worked with more than 6,000 partner surgeons and 4,000 partner healthcare centres.

Smile Train announces global cleft surgeries boost economies by £54 billion in more than 90 countries, according to new report

LivaNova to Present at the Goldman Sachs Healthcare Conference

Rachel Page, Chief Commercial Officer, Veristat (Photo: Business Wire)

Veristat Appoints New Chief Commercial Officer

PR Newswire associated0

Indivior to Host Analyst Teach-in Event in New York City; Reconfirms Full Year 2024 Guidance

PR Newswire associated0

NTC Ophthalmics lberica: Young ophthalmologists square in Zahara Los Atunes

New report from Access to Medicine Foundation shows what pharma companies can do to ensure the few promising antimicrobials in development reach patients on the frontlines of drug resistance